Presentation TCT 2021 How Do We Identify Patients With Microvascular Dysfunction and Define Their Risk (Pressure Wire, Angiography, MRI)? Presenter: Adrian Banning November 05, 2021
Presentation TCT 2021 Latest Evidence in the SPYRAL-HTN Clinical Program Presenter: NULL November 05, 2021
Presentation TCT 2021 Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective Presenter: George Van Hare November 05, 2021
Presentation TCT 2021 TCT 604: Hemoptysis From SVG Aneurysm Fistulization to Bronchial Tree Sealed With Covered Stent to Aneurysm Entrance Presenter: Christopher Wasco November 05, 2021
Presentation TCT 2021 Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective Presenter: Mintu Turakhia November 05, 2021
Presentation TCT 2021 Management of High Thrombus Burden: What Is the Role of Aspiration/ Intravenous Antipletelets/Intracoronary Lytic? Presenter: J. Dawn Abbott November 05, 2021
Presentation TCT 2021 Evidence gaps: What’s Needed in the New Guidelines? Presenter: David Cohen November 05, 2021
Presentation TCT 2021 Options for Immediate vs Staging Multivessel Revascularization in STEMI Presenter: Timothy Henry November 05, 2021
Presentation TCT 2021 Evidence Gaps: What’s Needed in the New Guidelines? Presenter: Rasha Al-Lamee November 05, 2021
Presentation TCT 2021 Left Atrial Appendage Interventions – Closing the Key Evidence Gaps to Move the Field Forward, From FDA Perspective Presenter: Kan Fang November 05, 2021